As an investor and a developer, Icade is an integrated real estate player that designs innovative real estate products and services adapted to new urban lifestyles and habits. A full property valuation of our portfolio is undertaken every six months and is reported in our May and November results. The dividend yield thus amounts to 2.8 % based on … Financial calendar.

PRESS RELEASE Issy-les-Moulineaux, November 25, 2019, 7:15 a.m. Interim Results for the six months ended 30 September 2020. 603.882.5200 iCAD is committed to corporate sustainability and to making a difference for our environment. Colliers International Acquires ICADE Asset Management and ICADE Conseil in France. Securities and Exchange Commission, EDGAR. To access all SEC filings for iCAD Inc., please visit: U.S. See the company profile for ICADE (ICAD.PA), including business summary, industry/sector information, number of employees, corporate governance, key executives and salary information.

The global pandemic had a significant impact on our business, our customers, and our … ICADE SANTE. icad Inc provides cancer detection, radiation therapy and workflow solutions, primarily computer-aided detection and workflow solutions for breast, prostate and colorectal cancers. Société Générale ESG/SRI Conference Presentation. Emmanuelle Baboulin corporate profile, background and performance evaluation including other Icade executives By suscribing to the Financial Alert, you agree that your contact information be kept by Klépierre or its technical service provider in order to send you the requested information. Emmanuelle Baboulin is Member of the Executive Committee in charge of the Commercial Property Investment Division of Icade Inc. In addition, we also hold a capital markets day on an annual basis. Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions.Head of investor relations +33 1 40 67 51 37. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter ended September 30, 2021, after the market close, and host a conference call at 4:30pm Eastern Time on Tuesday, November 9.

Icad investor relations